LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC ), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009. IMUC’s President and Chief Executive Officer, Manish Singh, Ph.D., will present an overview of the company’s business and strategy at 1:45pm at the Island Hotel in Newport Beach.
